Search hospitals > Iowa > Clive
Medical Oncology and Hematology Associates-West Des Moines
Claim this profileClive, Iowa 50325
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
394 reported clinical trials
2 medical researchers
Summary
Medical Oncology and Hematology Associates-West Des Moines is a medical facility located in Clive, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Medical Oncology and Hematology Associates-West Des Moines is involved with conducting 394 clinical trials across 470 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Clinical Trials running at Medical Oncology and Hematology Associates-West Des Moines
Lung Cancer
Bladder Cancer
Breast Cancer
Breast cancer
Multiple Myeloma
Pancreatic Cancer
Bladder Carcinoma
Cancer
Melanoma
Prostate Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Medical Oncology and Hematology Associates-West Des Moines?
Medical Oncology and Hematology Associates-West Des Moines is a medical facility located in Clive, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Medical Oncology and Hematology Associates-West Des Moines is involved with conducting 394 clinical trials across 470 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.
Where is Medical Oncology and Hematology Associates-West Des Moines located?
Medical Oncology & Hematology Associates is situated at 1221 Pleasant St, Des Moines, IA 50309, within the MercyOne Cancer Center at the MercyOne Des Moines Medical Center complex. For access, use the main entrance of the MercyOne Des Moines Medical Center and follow the signs to the West Building. The office is on the first floor of the West Building.
Who should I call to ask about financial aid or insurance network?
**Medical Oncology and Hematology Associates-West Des Moines Hospital Financial Assistance Overview:**
- **MercyOne Financial Assistance:** Eligible patients can apply for financial aid through MercyOne's Financial Assistance Policy. To qualify, applicants must provide details on household income and expenses, targeting uninsured or underinsured individuals with financial resources and/or income at or below 400% of the Federal Poverty Level. A list of providers covered by this policy is available.
- **UnityPoint Health Financial Assistance:** UnityPoint Health offers financial assistance to patients unable to afford their care. The policy includes a plain language summary, application form, and billing collections policy, with eligibility based on annual income guidelines and special circumstances considered individually.
Patients seeking financial assistance are encouraged to explore options with MercyOne and UnityPoint Health.
What insurance does Medical Oncology and Hematology Associates-West Des Moines accept?
Medical Oncology and Hematology Associates (MOHA) offers comprehensive cancer care and treatment. They accept various insurance plans. For detailed information on accepted insurance plans, please contact MOHA directly or visit their website.
What awards or recognition has Medical Oncology and Hematology Associates-West Des Moines received?
**Mission Cancer + Blood (Formerly Medical Oncology and Hematology Associates-West Des Moines)**
Located in Clive, Iowa, Mission Cancer + Blood was established in 1981 with a commitment to delivering immediate, compassionate care to patients facing cancer and blood disorders. Over the years, it has expanded its reach through numerous locations and partnerships with leading health systems, establishing itself as a benchmark for accessible, high-quality cancer care across Iowa.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.